Most Recent

image: Bad News for hESC Funding?

Bad News for hESC Funding?

By | December 12, 2011

Some are worried that the judges scheduled to hear arguments on the legality of federal support for human embryonic stem cell research will rule against stem cell funding.

3 Comments

image: EU Alliance Rejects hESC Ruling

EU Alliance Rejects hESC Ruling

By | December 9, 2011

A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.

3 Comments

image: An Eye for Stem Cells

An Eye for Stem Cells

By | December 1, 2011

Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.

36 Comments

image: Astronaut Worms Return from Space

Astronaut Worms Return from Space

By | December 1, 2011

After 6 months in orbit, Caenorhabditis elegans return to Earth—alive and well.

3 Comments

image: Eye of Newt

Eye of Newt

By | December 1, 2011

Researchers find that newts are capable of regenerating body parts well into old age.

3 Comments

image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42

5 Comments

image: Newts' New Eyes

Newts' New Eyes

By | December 1, 2011

Cut off a newt’s tail or a leg, or remove a lens from its eye, and it grows back. However, whether newts can continue to do this throughout their lives, or lose the ability as they get older, has remained a mystery. 

3 Comments

image: Flow Cytometry for the Masses

Flow Cytometry for the Masses

By | December 1, 2011

Tagging antibodies with rare earth metals instead of fluorescent molecules turns a veteran technique into a high-throughput powerhouse.

3 Comments

image: Human ES Cells Evolve in Culture

Human ES Cells Evolve in Culture

By | November 28, 2011

Researchers identify common genetic changes in cultured human embryonic stem cells, including one that confers a growth advantage.

4 Comments

image: First hESC Trial Kaput

First hESC Trial Kaput

By | November 15, 2011

Geron is terminating a clinical trial testing a human embryonic stem cell treatment for spinal cord injury.

30 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Vector Laboratories
Vector Laboratories
Advertisement
The Scientist
The Scientist